BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 16002800)

  • 1. Body composition and mortality in chronic obstructive pulmonary disease.
    Schols AM; Broekhuizen R; Weling-Scheepers CA; Wouters EF
    Am J Clin Nutr; 2005 Jul; 82(1):53-9. PubMed ID: 16002800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of weight loss in chronic obstructive pulmonary disease-related cachexia: a prospective cohort study.
    Kwan HY; Maddocks M; Nolan CM; Jones SE; Patel S; Barker RE; Kon SSC; Polkey MI; Cullinan P; Man WD
    J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1330-1338. PubMed ID: 31207189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Influence of Body Composition on Pulmonary Rehabilitation Outcomes in Chronic Obstructive Pulmonary Disease Patients.
    Tunsupon P; Mador MJ
    Lung; 2017 Dec; 195(6):729-738. PubMed ID: 28993936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inspiratory muscle strength, diaphragmatic mobility, and body composition in chronic obstructive pulmonary disease.
    Souza RMP; Cardim AB; Maia TO; Rocha LG; Bezerra SD; Marinho PÉM
    Physiother Res Int; 2019 Apr; 24(2):e1766. PubMed ID: 30628141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of body composition in COPD patients using multifrequency bioelectrical impedance analysis.
    de Blasio F; de Blasio F; Miracco Berlingieri G; Bianco A; La Greca M; Franssen FM; Scalfi L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2419-2426. PubMed ID: 27757027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data.
    Soriano JB; Lamprecht B; Ramírez AS; Martinez-Camblor P; Kaiser B; Alfageme I; Almagro P; Casanova C; Esteban C; Soler-Cataluña JJ; de-Torres JP; Miravitlles M; Celli BR; Marin JM; Puhan MA; Sobradillo P; Lange P; Sternberg AL; Garcia-Aymerich J; Turner AM; Han MK; Langhammer A; Leivseth L; Bakke P; Johannessen A; Roche N; Sin DD
    Lancet Respir Med; 2015 Jun; 3(6):443-50. PubMed ID: 25995071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of whole-body exercise training on body composition and functional capacity in normal-weight patients with COPD.
    Franssen FM; Broekhuizen R; Janssen PP; Wouters EF; Schols AM
    Chest; 2004 Jun; 125(6):2021-8. PubMed ID: 15189917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fat-Free Mass Index for Evaluating the Nutritional Status and Disease Severity in COPD.
    Luo Y; Zhou L; Li Y; Guo S; Li X; Zheng J; Zhu Z; Chen Y; Huang Y; Chen R; Chen X
    Respir Care; 2016 May; 61(5):680-8. PubMed ID: 26814217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body composition in patients with chronic obstructive pulmonary disease.
    Gologanu D; Ionita D; Gartonea T; Stanescu C; Bogdan MA
    Maedica (Bucur); 2014 Mar; 9(1):25-32. PubMed ID: 25553122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity.
    Ischaki E; Papatheodorou G; Gaki E; Papa I; Koulouris N; Loukides S
    Chest; 2007 Jul; 132(1):164-9. PubMed ID: 17505043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body composition by bioelectrical impedance predicts mortality in chronic obstructive pulmonary disease patients.
    Slinde F; Grönberg A; Engström CP; Rossander-Hulthén L; Larsson S
    Respir Med; 2005 Aug; 99(8):1004-9. PubMed ID: 15950141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mid-arm and calf circumferences are stronger mortality predictors than body mass index for patients with chronic obstructive pulmonary disease.
    Ho SC; Wang JY; Kuo HP; Huang CD; Lee KY; Chuang HC; Feng PH; Chen TT; Hsu MF
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2075-80. PubMed ID: 27621613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between physical capacity, nutritional status and systemic inflammation in COPD.
    Hallin R; Janson C; Arnardottir RH; Olsson R; Emtner M; Branth S; Boman G; Slinde F
    Clin Respir J; 2011 Jul; 5(3):136-42. PubMed ID: 21679348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease.
    Marquis K; Debigaré R; Lacasse Y; LeBlanc P; Jobin J; Carrier G; Maltais F
    Am J Respir Crit Care Med; 2002 Sep; 166(6):809-13. PubMed ID: 12231489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Impact of Low Fat-Free Mass in People With COPD Based on BMI Classifications: Results From the COPD and Systemic Consequences-Comorbidities Network.
    Machado FVC; Vogelmeier CF; Jörres RA; Watz H; Bals R; Welte T; Spruit MA; Alter P; Franssen FME
    Chest; 2023 May; 163(5):1071-1083. PubMed ID: 36470414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body composition markers in older persons with COPD.
    Abbatecola AM; Fumagalli A; Spazzafumo L; Betti V; Misuraca C; Corsonello A; Cherubini A; Guffanti EE; Lattanzio F
    Age Ageing; 2014 Jul; 43(4):548-53. PubMed ID: 24366838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body resting and exercise-induced lipolysis in sarcopenic [corrected] patients with COPD.
    Franssen FM; Sauerwein HP; Rutten EP; Wouters EF; Schols AM
    Eur Respir J; 2008 Dec; 32(6):1466-71. PubMed ID: 18579550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Assessment of Erector Spinae Muscles in Patients with Chronic Obstructive Pulmonary Disease. Novel Chest Computed Tomography-derived Index for Prognosis.
    Tanimura K; Sato S; Fuseya Y; Hasegawa K; Uemasu K; Sato A; Oguma T; Hirai T; Mishima M; Muro S
    Ann Am Thorac Soc; 2016 Mar; 13(3):334-41. PubMed ID: 26700501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body composition parameters and functional status test in predicting future acute exacerbation risk among hospitalized patients with chronic obstructive pulmonary disease.
    Karanikas I; Karayiannis D; Karachaliou A; Papanikolaou A; Chourdakis M; Kakavas S
    Clin Nutr; 2021 Nov; 40(11):5605-5614. PubMed ID: 34656957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fat-free mass depletion in patients with COPD in Brazil: development of a new cutoff point and its relation with mortality and extrapulmonary manifestations.
    Travassos A; Rodrigues A; Furlanetto KC; Donária L; Bisca GW; Nellessen AG; Pitta F; Hernandes NA
    Eur J Clin Nutr; 2017 Nov; 71(11):1285-1290. PubMed ID: 28722028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.